GSK responds to the recent court ruling on the COMPAS study in Mendoza, Argentina
11 January 2012 | By GlaxoSmithKline
GlaxoSmithKline respectfully disagrees with the recent court ruling in favour of ANMAT...
List view / Grid view
News
AstraZeneca and IMS Health announce real-world evidence collaboration in Europe
11 January 2012 | By AstraZeneca
AstraZeneca has entered into a three-year collaboration agreement with IMS Health...
Sanofi and Venture Capital Firms, Third Rock Ventures and Greylock Partners, jointly launch Warp Drive Bio
10 January 2012 | By Sanofi
Sanofi is co-investing in Warp Drive Bio, an innovative start-up biotechnology company...
SFJ Pharma Ltd. II announces agreement with Pfizer to develop Axitinib
9 January 2012 | By Citigate Dewe Rogerson
SFJ announced that it has entered into a collaborative development agreement with Pfizer Inc. to conduct a Phase 3 clinical trial...
AstraZeneca reaffirms December 2011 financial guidance for 2011 and mid-term planning assumptions for the 2010 to 2014 period
9 January 2012 | By AstraZeneca
The info was out of date planning information...
GSK and Theravance announce initial outcomes from pivotal Phase III studies
9 January 2012 | By GlaxoSmithKline
GSK and Theravance, Inc. announced the completion of the phase III registration programme...
Novartis Consumer Health Inc. voluntarily recalls certain over-the-counter products in the US
8 January 2012 | By Novartis
There have been no related adverse events reported with the issues leading to the recall...
Bristol-Myers Squibb to acquire Inhibitex
7 January 2012 | By Bristol-Myers Squibb
Bristol-Myers Squibb to acquire Inhibitex for $26.00 per share in cash pursuant to a cash tender offer and second step merger...
New Director Sales and Business Development for GEA Pharma Systems in Latin America
6 January 2012 | By The Words Workshop Ltd
GEA Pharma Systems has appointed Zósimo López Moreno...
FDA approves Merck’s ISENTRESS® (raltegravir)
6 January 2012 | By Merck
The U.S. FDA recently approved the use of ISENTRESS® (raltegravir) in combination with other antiretroviral (ARV) medicines...
Gilead Sciences announces early termination of Hart-Scott-Rodino waiting period
6 January 2012 | By Gilead Sciences
Gilead Sciences, Inc. has received early termination of the required waiting period...
Merck Millipore collaborates with Peking University
5 January 2012 | By Merck Millipore
Merck Millipore, announced that the division was invited to serve on the faculty of the CPIER at Peking University...
Biogen Idec and Isis Pharmaceuticals announce global collaboration
4 January 2012 | By Biogen Idec
Biogen Idec and Isis Pharmaceuticals, Inc. have entered into an exclusive, worldwide option and collaboration agreement...
Tivozanib demonstrated superiority over sorafenib in patients with advanced renal cell cancer in Phase 3 TIVO-1 trial
4 January 2012 | By Astellas
Tivozanib has demonstrated superiority over sorafenib...
Advanced magnetic resonance imaging technology suggests axonal repair in MS patients treated with COPAXONE®
3 January 2012 | By Teva
Study findings published in Frontiers in Bioscience...
